NCT07760623Not yet recruiting
Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension
Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension (CRF Survey)
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
To evaluate both sides of the common carotid artery, renal artery, and femoral artery in Hypertension patient that cause of systemic arterial hypertension and/or the effects of target organ damage, both structural and functional markers.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 30 Jul 2026
- Start date
- 15 Nov 2026
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- DejthidaNathaphong
- Diseases
- High blood pressure
- NCT number
- NCT07760623
What you commit to
- Study type: Observational
- Planned participants: 100
- From 15 Nov 2026 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Fatal pathology and imaging
- Pediatric or pregnant participants
- Small vessel angiogram
- Intravascular endoscopy
- Intra-operative estimation
Who the study is looking for
- Adults ≥18 years with diagnosed hypertension by a clinician, both untreated and treated, including successfully treated participants.
- Imaging evidence of at least 1 list of
- Common carotid artery
- Renal artery
- Femoral artery
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Invstigation center Coordinator of this site? Confirm its status | Vadhana | Thailand | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.